Metabolic syndrome update.
Grundy SM.
Trends Cardiovasc Med. 2016 May;26(4):364-73. doi: 10.1016/j.tcm.2015.10.004. Epub 2015 Oct 31.
Cutaneous Manifestations of Diabetes Mellitus and Prediabetes.
Sanches MM, Roda Â, Pimenta R, Filipe PL, Freitas JP.
Acta Med Port. 2019 Jun 28;32(6):459-465. doi: 10.20344/amp.10738.
The gut microbiome and metabolic syndrome.
Dabke K, Hendrick G, Devkota S.
J Clin Invest. 2019 Oct 1;129(10):4050-4057. doi: 10.1172/JCI129194.
Hyperinsulinemia associated with acanthosis nigricans, finger pebbles, acrochordons, and the sign of Leser-Trelat.
Saraiya A, Al-Shoha A, Brodell RT.
Endocr Pract. 2013 May-Jun;19(3):522-5. doi: 10.4158/EP12192.RA.
Cutaneous Manifestations of Diabetes.
Hines A, Alavi A, Davis MDP.
Med Clin North Am. 2021 Jul;105(4):681-697. doi: 10.1016/j.mcna.2021.04.008.
Acanthosis nigricans.
Stuart CA, Driscoll MS, Lundquist KF, Gilkison CR, Shaheb S, Smith MM.
J Basic Clin Physiol Pharmacol. 1998;9(2-4):407-18. doi: 10.1515/JBCPP.1998.9.2-4.407.
Obesity and dyslipidemia.
Franssen R, Monajemi H, Stroes ES, Kastelein JJ.
Med Clin North Am. 2011 Sep;95(5):893-902. doi: 10.1016/j.mcna.2011.06.003.
Diabetes mellitus and the skin.
Mendes AL, Miot HA, Haddad V Junior.
An Bras Dermatol. 2017 Jan-Feb;92(1):8-20. doi: 10.1590/abd1806-4841.20175514.
Assessment of patients with acanthosis nigricans skin lesion for hyperinsulinemia, insulin resistance and diabetes risk.
Gilkison C, Stuart CA.
Nurse Pract. 1992 Feb;17(2):26, 28, 37 passim. doi: 10.1097/00006205-199202000-00013.
Postprandial Dyslipidemia, Hyperinsulinemia, and Impaired Gut Peptides/Bile Acids in Adolescents with Obesity.
Higgins V, Asgari S, Hamilton JK, Wolska A, Remaley AT, Hartmann B, Holst JJ, Adeli K.
J Clin Endocrinol Metab. 2020 Apr 1;105(4):1228-41. doi: 10.1210/clinem/dgz261.
